Day's Trending USA Stocks | Quantum: Overnight gain 64.7%, Surges Amid Strong Q1 Earnings Beat, Debt Elimination, and Record Backlog

Quantum Corporation
NEURONETICS, INC.
NIQ Global Intelligence PLC
Concorde International Group
Alamar Biosciences, Inc.

Quantum Corporation

QMCO

0.00

NEURONETICS, INC.

STIM

0.00

NIQ Global Intelligence PLC

NIQ

0.00

Concorde International Group

CIGL

0.00

Alamar Biosciences, Inc.

ALMR

0.00

Editor's Note: the "Trending USA Stocks" column tracks the day's top bullish stocks in the USA market, aiding investors in promptly identifying opportunities for potential gains.

11/08/2026 Eastern Time in USA The Dow Jones Industrial Average dropped by 0.34%, closing at 53791.85 points; the Nasdaq Composite dropped by 0.6%, closing at 26445.45 points; the S&P 500 Index dropped by 0.32%, closing at 7728.2 points. Sahm has compiled the Top 10 Daily Stock Price Gainers in the USA market.

The Top 10 Daily Gainers in the USA market are listed as follows:

Company&Ticker

Cap$bn

Daily Change

YTD Change

Quantum Corporation(QMCO.US)0.7664.7%200.8%
NEURONETICS, INC.(STIM.US)0.2247.0%131.2%
NIQ Global Intelligence PLC(NIQ.US)4.8942.0%0.5%
Concorde International Group(CIGL.US)0.1432.5%-63.0%
Alamar Biosciences, Inc.(ALMR.US)2.5430.6%115.1%
Alector(ALEC.US)0.2323.7%34.0%
Kopin Corporation(KOPN.US)0.9523.5%122.2%
FutureFuel Corp.(FF.US)0.2823.4%104.2%
Septerna, Inc.(SEPN.US)2.2322.9%71.3%
Fermi Inc.(FRMI.US)4.5421.1%-11.0%

Quantum Corporation: Overnight gain 64.7%, Surges Amid Strong Q1 Earnings Beat, Debt Elimination, and Record Backlog

**Quantum Corporation: A Global Leader in Data Protection and Big Data Management** Founded in 1980, Quantum Corporation has established itself as a preeminent authority in the global data protection and big data management landscape. The company specializes in delivering comprehensive information storage and protection solutions tailored for physical, virtual, cloud, and big data environments, empowering clients to maximize the value of data across its entire lifecycle. Through its suite of innovative solutions, Quantum enables organizations to extend data retention periods while simultaneously reducing operational costs and enhancing return on investment, thereby strengthening their resilience and agility in response to evolving market dynamics. To address the continuously shifting data management requirements of its clientele, the company has cultivated an extensive partner ecosystem encompassing resellers, value-added distributors, direct marketers, and original equipment manufacturers (OEMs), ensuring broad market reach and comprehensive service delivery across multiple channels.

Quantum Corporation(QMCO.US) Surges 64.7% Following Blowout Q1 FY2027 Results** Quantum Corporation(QMCO) shares skyrocketed 64.7% in a single session, bringing year-to-date gains to an impressive 200.8%, driven by a confluence of strong fundamental catalysts. The company reported Q1 FY2027 revenue of $80.8 million, representing a 26% year-over-year increase and significantly surpassing analyst consensus estimates of $74.75 million. Adjusted EPS came in at $0.02–$0.22, dramatically outperforming market expectations of a $0.03 loss, marking the company's first non-GAAP profitability since FY2023. Product revenue surged 43.5% year-over-year, while gross margins expanded meaningfully from 35.3% to 39.3%. Quantum Corporation(QMCO) also completed a comprehensive balance sheet restructuring, fully eliminating all outstanding debt obligations and substantially strengthening its financial position. Additionally, the company's order backlog reached an all-time high, with forward guidance for the upcoming quarter remaining decidedly optimistic.

NEURONETICS, INC.: Overnight gain 47.0%, Surges After Q2 Earnings Beat Expectations on EPS and Revenue

**Neuronetics, Inc. Company Overview** Neuronetics, Inc., incorporated in the State of Delaware in April 2003, is a commercial-stage medical technology company dedicated to the design, development, and commercialization of products aimed at improving the quality of life for patients suffering from psychiatric disorders. The Company's flagship commercial product, the NeuroStar Advanced Therapy System, leverages Transcranial Magnetic Stimulation (TMS) technology to deliver therapeutic outcomes through a non-invasive, non-systemic outpatient treatment modality. The system operates by generating pulsed magnetic fields of MRI-strength intensity to induce targeted electrical currents, thereby stimulating discrete cortical regions of the brain associated with mood regulation. The NeuroStar Advanced Therapy System has received clearance from the U.S. Food and Drug Administration (FDA) for the treatment of adult patients diagnosed with Major Depressive Disorder (MDD) who have demonstrated an inadequate clinical response to prior antidepressant pharmacotherapy during their current depressive episode.

NEURONETICS, INC.(STIM.US) Surges 47.0% Following Robust Q2 Earnings Beat** Shares of NEURONETICS, INC. (STIM) posted a remarkable single-session gain of 47.0% after the company reported second-quarter financial results that comprehensively exceeded market expectations. The company recorded a loss per share of $(0.05), significantly outperforming the consensus analyst estimate of $(0.13) by 58.33%, while representing a 66.67% improvement compared to the $(0.15) loss per share reported in the prior-year period. Quarterly revenue reached $41.57 million, surpassing expectations by 3.47% and reflecting a year-over-year increase of 9.08%. The dual outperformance across both earnings per share and top-line revenue served as a powerful positive catalyst, driving substantial investor confidence. Year-to-date, STIM shares have surged 131.2%, with the company's current market capitalization standing at approximately $222 million.

NIQ Global Intelligence PLC: Overnight gain 42.0%, Surges Amid Strong Earnings Beat, Raised Guidance, and Bullish Analyst Upgrades

**NIQ Global Intelligence PLC** NIQ Global Intelligence PLC, incorporated in Ireland on June 6, 2017, is a world-leading consumer intelligence company dedicated to connecting brands, retailers, and consumers across the global marketplace. Leveraging an AI-powered, unified technology platform, the Company aggregates, harmonizes, and processes vast volumes of global consumer purchasing data at scale, generating proprietary reference data and metadata while delivering a comprehensive, full-spectrum view of consumer shopping behavior across all channels worldwide.

NIQ Global Intelligence PLC(NIQ.US) Surges 42% on Strong Q2 Beat and Raised Guidance** Shares of NIQ Global Intelligence PLC (NIQ) soared 42% in a single session, driven by a confluence of bullish catalysts. The company reported Q2 adjusted EPS of $0.27, surpassing consensus estimates by approximately 35% and marking a remarkable 1,450% year-over-year turnaround. Revenue came in at $1.124 billion, up roughly 7.97% year-over-year and exceeding expectations by approximately 1.65%. Management also raised its FY2026 outlook, lifting adjusted EPS guidance to $1.08–$1.12 and revenue guidance to $4.496–$4.510 billion, both above analyst forecasts. The rally was further bolstered by positive analyst actions: Needham initiated coverage with a Buy rating and an $18 price target, while Wells Fargo reiterated its Overweight rating and raised its price target from $13 to $16.50, amplifying the stock's sharp single-day advance.

Concorde International Group: Overnight gain 32.5%, Surges Amid Technical Rebound, Small Float, and Growing Southeast Asia Security Demand

**Concorde International Group Limited**, incorporated in the British Virgin Islands on May 2, 2023, with its principal operations headquartered in Singapore, is an integrated security services provider that synergizes physical manpower resources with advanced technology to deliver a comprehensive suite of security solutions, encompassing intelligent security systems, manned guarding services, as well as consultancy and training offerings.

Concorde International Group(CIGL.US) Surges 32.5% Overnight Amid Technical Rebound** Shares of Concorde International Group (CIGL) posted a sharp overnight gain of 32.5%, drawing significant market attention. Analysts attribute the rally to a confluence of factors. First, the stock had accumulated a steep year-to-date decline of approximately 63.0%, placing it in deeply oversold territory and creating substantial pent-up momentum for a technical correction rebound. Second, as a small-capitalization company incorporated in 2023 and primarily engaged in security services in Singapore, CIGL's limited float means that relatively modest capital inflows can generate considerable price elasticity. Third, the company's integrated business model — combining traditional manned security with intelligent technology solutions — aligns well with the growing demand for security services across Southeast Asia, providing a degree of fundamental support. Investors are advised to monitor subsequent trading volumes and any forthcoming corporate disclosures for further directional clarity.

Alamar Biosciences, Inc.: Overnight gain 30.6%, Surges Amid Subsidiary Attovia's Nasdaq IPO Success and Raised Revenue Guidance

**Alamar Biosciences, Inc. — Company Overview** Alamar Biosciences, Inc. was incorporated in the State of Delaware in May 2018 and is headquartered in Fremont, California. The Company is a commercial-stage proteomics enterprise dedicated to establishing industry standards in protein detection and analysis. Its flagship proprietary NULISA™ platform delivers ultra-high sensitivity, high specificity, and a broad dynamic range, enabling flexible and highly multiplexed detection of low-abundance protein biomarkers in non-invasive biological fluids — advancing the frontier of what the Company terms "precision proteomics." Alamar Biosciences offers customers an integrated suite of solutions encompassing instrumentation, consumables, and analytical software, with broad applications spanning biomarker discovery, translational research, and diagnostic development.

Alamar Biosciences, Inc.(ALMR.US) Surges 30.6% on Spinoff IPO Success and Raised Guidance** Shares of Alamar Biosciences, Inc. (ALMR) soared 30.6% in a single session, bringing year-to-date gains to 115.1%, driven by multiple converging catalysts. The primary driver was the successful Nasdaq debut of spinoff Attovia Therapeutics (ATTO), which priced its IPO at $17 per share and closed up 28.82% at $21.90 on its first trading day, achieving a market capitalization exceeding $900 million — prompting a significant market reassessment of Alamar's underlying asset value. As the exclusive global licensor of the ATTOBODY biologics platform, Alamar Biosciences, Inc. (ALMR) stands to benefit from potential milestone payments and royalty revenues tied to Attovia's pipeline advancement, including ATTO-1310, which carries peak sales projections exceeding $11 billion. Additionally, Alamar Biosciences, Inc. (ALMR) raised its fiscal year 2026 revenue guidance to $116–$120 million, surpassing analyst consensus estimates, further reinforcing fundamental support.

Alector: Overnight gain 23.7%, Surges Amid Gulf Infrastructure Boom, Backed by Saudi Vision 2030 and Government Support

# ALEC Holdings PJSC: A Market-Leading Diversified Engineering & Construction Group Anchored in the UAE and Saudi Arabia **ALEC Holdings PJSC ("ALEC")** is a market-leading, diversified engineering and construction conglomerate with a primary focus on large-scale, iconic built environment and energy infrastructure projects across the United Arab Emirates and the Kingdom of Saudi Arabia. Founded in 1999, the Group became a wholly owned subsidiary of the Investment Corporation of Dubai ("ICD") in 2017, positioning ALEC in close strategic alignment with the broader development vision of the Government of Dubai. ALEC operates through an integrated, multi-disciplinary platform encompassing fit-out, mechanical, electrical and plumbing (MEP), modular construction, data centres, energy solutions, façade engineering, and renewable energy. This vertically integrated business model delivers meaningful operational synergies across cost management, quality assurance, and supply chain optimisation, enabling the Group to offer clients a comprehensive, end-to-end project delivery capability. Underpinned by a proven track record across high-complexity asset classes — including airports, hospitality, retail, ultra-luxury high-rise residential, and themed entertainment — ALEC has established itself as the contractor of choice for clients seeking technically sophisticated, high-value project execution.

Alector(ALEC.US) Surges 23.7% Overnight Amid Gulf Infrastructure Boom** Shares of Alector(ALEC), a leading diversified engineering and construction conglomerate operating across the UAE and Saudi Arabia, posted a remarkable 23.7% overnight gain, bringing year-to-date cumulative returns to 34.0%. The rally is underpinned by robust order momentum driven by Saudi Arabia's Vision 2030 initiative and Dubai's urban development masterplan, both of which continue to generate substantial project pipelines for the group. Alector(ALEC)'s strategic positioning in data center solutions and renewable energy aligns with high-conviction global capital market themes, commanding a notable valuation premium among institutional investors. As a subsidiary of Investment Corporation of Dubai (ICD), the company benefits from strong government strategic endorsement, significantly bolstering investor confidence. Its proven track record in delivering high-value projects — including international airports and ultra-luxury supertall developments — has further catalyzed positive market sentiment and multiple expansion.

Kopin Corporation: Overnight gain 23.5%, Surges After Q2 Sales Beat Expectations, Driven by Defense and AR/VR Demand

**Kopin Corporation: A Pioneer in Microdisplay Technology and Optical Systems** Founded in 1984 and incorporated in the State of Delaware, Kopin Corporation stands as an industry leader in the research, development, and innovation of microdisplay technologies and optical systems. The Company operates across a diversified portfolio of end markets, encompassing defense, enterprise, industrial, consumer, and medical sectors. Its core product offerings include Active Matrix Liquid Crystal Displays (AMLCDs), Liquid Crystal on Silicon (LCoS) displays, Organic Light-Emitting Diode (OLED) displays, and MicroLED displays, complemented by customized application-specific optical subsystem solutions tailored to meet the demands of its broad client base.

Kopin Corporation(KOPN.US) Surges 23.5% After Q2 Sales Beat Expectations** Shares of Kopin Corporation (KOPN) soared 23.5% in a single session after the company reported second-quarter sales results that significantly exceeded market consensus, bringing its year-to-date cumulative gain to an impressive 122.2%. The microdisplay technology specialist, whose AMLCD and OLED display solutions are widely deployed in military head-mounted systems, continues to benefit from sustained growth in defense procurement contracts. Additional tailwinds emerged from a recovery in enterprise and industrial optical subsystem demand, alongside a broader rebound in the AR/VR wearable technology market, collectively bolstering the company's top-line performance. The robust quarterly results reaffirm Kopin Corporation's (KOPN) entrenched competitive advantages and deep technological moat in microdisplay and optical systems. The strong earnings catalyst materially lifted market sentiment, driving the double-digit share price advance.

FutureFuel Corp.: Overnight gain 23.4%, Surges Amid Strong Q2 Earnings, Driven by Chemicals and Biofuels Recovery

**FutureFuel Corp. Company Overview** FutureFuel Corp. is a Delaware-incorporated entity, established on August 12, 2005, with its principal executive offices headquartered in St. Louis, Missouri. The Company conducts its operations through its wholly-owned subsidiary, FutureFuel Chemical Company, engaging in the manufacture of diversified chemicals, biobased fuels, and biobased specialty chemicals. Its core business operations are organized into two reportable segments: the Chemicals segment and the Biofuels segment.

FutureFuel Corp.(FF.US) Surges 23.4% on Stellar Q2 Earnings Beat** FutureFuel Corp. (FF) shares experienced a remarkable single-session rally of 23.4%, driven by the company's robust second-quarter financial results, which served as the primary catalyst for the sharp price appreciation. Q2 earnings per share reached $0.25, representing a substantial year-over-year improvement of 204.17% compared to a loss of $0.24 per share in the prior-year period, marking a decisive return to profitability. Quarterly revenue surged 120.69% year-over-year to $78.73 million, nearly doubling the company's top-line figures. The significantly better-than-expected performance materially bolstered investor confidence, propelling FutureFuel Corp. (FF) to a year-to-date cumulative gain of 104.2%. As a diversified operator spanning both specialty chemicals and biofuels segments, the company's dual-business structure proved instrumental in underpinning its strong financial recovery.

Septerna, Inc.: Overnight gain 22.9%, Surges Amid Clinical Pipeline Catalysts and Proprietary GPCR Platform Valuation Premium

**Septerna, Inc.: Clinical-Stage Biotech Pioneer in GPCR-Targeted Small Molecule Drug Discovery** Septerna, Inc. was incorporated in the State of Delaware in December 2019 under its original name, GPCR NewCo, Inc., and subsequently rebranded under its current name in June 2021. The Company is a clinical-stage biopharmaceutical enterprise that is pioneering the discovery of oral small molecule therapeutics targeting G protein-coupled receptors (GPCRs) through its proprietary Native Complex Platform™. This industry-scale platform is purpose-built to unlock the full therapeutic potential of GPCR-directed medicines and to accelerate the discovery and development of a deep and differentiated pipeline of drug candidates. The Company's current strategic focus spans three core therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases.

Septerna, Inc.(SEPN.US) Surges 22.9% Overnight, Posting 71.3% Year-to-Date Gain** Shares of Septerna, Inc. (SEPN) delivered a remarkable overnight surge of 22.9%, bringing its year-to-date cumulative gain to an impressive 71.3%, driven by a confluence of multiple catalysts. In the near term, as a clinical-stage biopharmaceutical company focused on endocrinology, immunology, inflammation, and metabolic diseases, such sharp single-session rallies are typically associated with significant pipeline catalysts, including the disclosure of clinical trial data for lead drug candidates. Over the longer term, Septerna, Inc. (SEPN) continues to command a meaningful valuation premium, underpinned by its proprietary Native Complex Platform™ technology. The company's differentiated approach to developing oral small-molecule therapeutics targeting G protein-coupled receptors (GPCRs) has reinforced investor confidence, sustaining the stock's robust 71.3% year-to-date appreciation and highlighting its distinctive competitive positioning within the biotechnology sector.

Fermi Inc.: Overnight gain 21.1%, Surges Amid Landmark AI Data Center Lease Agreement With TensorWave

**Fermi Inc. Launches with Mission to Power Next-Generation AI Infrastructure Through Integrated Energy and Hyperscale Data Center Development** Fermi Inc. was incorporated on January 10, 2025, positioning itself at the intersection of advanced energy solutions and hyperscale data center development, with a strategic focus on addressing the accelerating demand for artificial intelligence infrastructure. The company's core mandate centers on delivering low-carbon, high-redundancy, and on-demand power solutions tailored to the requirements of compute-intensive enterprises — a segment experiencing unprecedented capacity constraints amid the global AI buildout. Central to Fermi Inc.'s growth strategy is **Project Matador**, a flagship integrated energy and data center development campus designed to harness a diversified generation mix comprising natural gas, nuclear, and solar power. The project is engineered to operate independently of public utility grids, enabling stable, uninterrupted computing capacity with enhanced resilience against grid volatility and supply disruptions. By vertically integrating energy production with data center infrastructure, Fermi Inc. aims to offer institutional and enterprise clients a differentiated value proposition — combining energy sovereignty, carbon responsibility, and scalable computational power under a single development framework.

Fermi Inc.(FRMI.US) Shares Surge Following Landmark AI Data Center Lease Agreement** Shares of Fermi Inc. (FRMI) rallied after the company announced on August 10 the execution of its first binding customer lease with TensorWave TEX1, LLC, a subsidiary of AI cloud services provider TensorWave. The agreement covers a 222-megawatt facility at the Matador project campus in Carson County, Texas, with an initial 15-year term expected to generate approximately $6.5 billion in contracted revenue. The lease includes options for two additional data center expansions, which, if fully exercised, would scale the partnership to over 650 megawatts. The Matador project has received approval for approximately 6 gigawatts of capacity, with cumulative investment exceeding $1.5 billion. Initial deliveries are anticipated to commence in the second half of 2027. Market confidence was further bolstered by the company's disclosure that certain lease obligations will be guaranteed by a leading global AI enterprise.

Editor's note: This content was generated by Sahm's in-house AI-enabled SaaS tool and was reviewed by our editing team. Risk and Disclaimer: The content provided above is solely for informational purposes and does not represent the views or positions of Sahm Platform. While we strive for accuracy, we cannot guarantee the authenticity or completeness of the information contained in the provided content. We strongly recommend that investors consult with a qualified investment advisor when deemed necessary. Sahm Platform neither provides investment advice nor makes any representations or warranties concerning the accuracy, reliability, or completeness of the information in the content provided above. By using Sahm Platform, you acknowledge that you have read, understood, and agreed to the terms set forth in this disclaimer.